Article
Development, safety, and efficacy of biosimilar adalimumab: the data so far
Ceased publishing: Biosimilars · 2016 · Gabbani T, Deiana S, Bagnoli S, Annese V
Key facts
| Title | Development, safety, and efficacy of biosimilar adalimumab: the data so far |
|---|---|
| First author | Gabbani T, Deiana S, Bagnoli S, Annese V |
| Journal | Ceased publishing: Biosimilars |
| Published | Jan 29, 2016 |
| DOI | 10.2147/BS.S55900 |
| Devices mentioned | 004040, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 3 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, GGT, KLB and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1